-
1دورية أكاديمية
المؤلفون: de Jong EMGJ, van de Kerkhof PCM, Boezeman J B, Berends MAM, Driessen RJB, Van Lümig PPM
المصدر: Journal of Translational Medicine, Vol 8, Iss Suppl 1, p P16 (2010)
مصطلحات موضوعية: Medicine
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1479-5876
-
2دورية أكاديمية
المؤلفون: Atalay S; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands., Berends SE; Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, Netherlands., Groenewoud HMM; Department for Health Evidence, Radboud Institute for Health Sciences, Radboudumc, Nijmegen, Netherlands., Mathot RAA; Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, Netherlands., Njoo DM; Department of Dermatology, Ziekenhuis Groep Twente, Hengelo, Netherlands., Mommers JM; Department of Dermatology, Sint Anna Ziekenhuis, Geldrop, Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuis Groep Twente, Almelo, Netherlands., Koetsier MIA; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, Netherlands., Berends MA; Department of Dermatology, Slingelandziekenhuis, Doetinchem, Netherlands., de Vries A; Biologics Lab, Bioanalysis, Sanquin Diagnostic Services, Amsterdam, Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands., de Jong EMGJ; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands.; Radboud University, Nijmegen, Netherlands., van den Reek JMPA; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands.
المصدر: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Aug; Vol. 33 (5), pp. 2680-2684. Date of Electronic Publication: 2022 Feb 23.
نوع المنشور: Journal Article; Randomized Controlled Trial
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE
مواضيع طبية MeSH: Biological Products*/therapeutic use , Psoriasis*/drug therapy, Adalimumab ; Biological Factors/therapeutic use ; Drug Tapering ; Etanercept ; Humans ; Treatment Outcome ; Ustekinumab
-
3دورية أكاديمية
المؤلفون: Atalay S; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., van Vugt LJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Njoo MD; Department of Dermatology, Ziekenhuis Groep Twente, Hengelo, the Netherlands., Mommers JM; Department of Dermatology, Sint Anna Ziekenhuis, Geldrop, the Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuis Groep Twente, Almelo, the Netherlands., Koetsier MI; Department of Dermatology, Gelre ziekenhuizen, Apeldoorn, the Netherlands., Berends MA; Department of Dermatology, Slingelandziekenhuis, Doetinchem, the Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Groenewoud HMM; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., Kievit W; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
المصدر: JAMA dermatology [JAMA Dermatol] 2020 Apr 01; Vol. 156 (4), pp. 393-400.
نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Adalimumab/*administration & dosage , Dermatologic Agents/*administration & dosage , Etanercept/*administration & dosage , Psoriasis/*drug therapy , Ustekinumab/*administration & dosage, Adult ; Aged ; Biological Products/administration & dosage ; Drug Tapering ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Prospective Studies ; Psoriasis/pathology ; Quality of Life ; Severity of Illness Index ; Treatment Outcome
-
4دورية أكاديمية
المؤلفون: Zweegers J; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Roosenboom B; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van de Kerkhof PC; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Atalay S; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Kuijpers AL; Maxima Medisch Centrum, Eindhoven/Veldhoven, the Netherlands., Koetsier MI; Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Arnold WP; Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Berends MA; Slingeland Ziekenhuis, Doetinchem, the Netherlands., Weppner-Parren L; Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands., Bijen M; Ziekenhuisgroep Twente, Almelo/Hengelo, the Netherlands., Njoo MD; Ziekenhuisgroep Twente, Almelo/Hengelo, the Netherlands., Mommers JM; St. Anna Ziekenhuis, Geldrop, the Netherlands., van Lümig PP; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Driessen RJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Kievit W; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Nijmegen, Nijmegen, the Netherlands.
المصدر: The British journal of dermatology [Br J Dermatol] 2017 Mar; Vol. 176 (3), pp. 786-793. Date of Electronic Publication: 2016 Oct 07.
نوع المنشور: Journal Article; Multicenter Study
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Biological Factors/*therapeutic use , Psoriasis/*drug therapy, Adalimumab/therapeutic use ; Etanercept/therapeutic use ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome ; Ustekinumab/therapeutic use
-
5دورية أكاديمية
المؤلفون: Zweegers J; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., van de Kerkhof PC; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Kuijpers AL; Maxima Medisch Centrum, Eindhoven/Veldhoven, the Netherlands., Koetsier MI; Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Arnold WP; Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Berends MA; Slingeland Ziekenhuis, Doetinchem, the Netherlands., Weppner-Parren L; Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands., Ossenkoppele PM; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Njoo MD; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Mommers JM; St Anna Ziekenhuis, Geldrop, the Netherlands., van Lümig PP; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Driessen RJ; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Kievit W; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University, Nijmegen, the Netherlands.
المصدر: The British journal of dermatology [Br J Dermatol] 2016 Aug; Vol. 175 (2), pp. 340-7. Date of Electronic Publication: 2016 Jun 25.
نوع المنشور: Comparative Study; Journal Article; Multicenter Study
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Adalimumab/*adverse effects , Anti-Inflammatory Agents/*adverse effects , Etanercept/*adverse effects , Psoriasis/*drug therapy , Ustekinumab/*adverse effects, Adalimumab/administration & dosage ; Anti-Inflammatory Agents/administration & dosage ; Biological Factors/adverse effects ; Body Mass Index ; Drug Administration Schedule ; Drug Substitution ; Etanercept/administration & dosage ; Female ; Humans ; Kaplan-Meier Estimate ; Long-Term Care ; Male ; Middle Aged ; Prospective Studies ; Registries ; Sex Characteristics ; Ustekinumab/administration & dosage
-
6دورية أكاديمية
المؤلفون: van Lümig PP; Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. P.vanLumig@derma.umcn.nl, Driessen RJ, Berends MA, Boezeman JB, van de Kerkhof PC, de Jong EM
المصدر: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2012 Mar; Vol. 26 (3), pp. 283-91. Date of Electronic Publication: 2011 Mar 24.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
مواضيع طبية MeSH: Biological Products/*therapeutic use , Psoriasis/*drug therapy, Aged ; Biological Products/adverse effects ; Biomarkers/blood ; Comorbidity ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Poisson Distribution ; Prospective Studies ; Registries ; Treatment Outcome
-
7دورية أكاديمية
المؤلفون: van Lingen RG; Department of Dermatology, Radboud University, Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. R.vanlingen@derma.umcn.nl, Körver JE, van de Kerkhof PC, Berends MA, van Rens DW, Langewouters AM, Boezeman JB, Seyger MM, de Jong EM
المصدر: The British journal of dermatology [Br J Dermatol] 2008 Jul; Vol. 159 (1), pp. 91-6. Date of Electronic Publication: 2008 Jul 01.
نوع المنشور: Journal Article; Randomized Controlled Trial
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Dermatologic Agents/*therapeutic use , Immunoglobulin G/*therapeutic use , Immunosuppressive Agents/*therapeutic use , Psoriasis/*drug therapy , Receptors, Tumor Necrosis Factor/*therapeutic use , T-Lymphocyte Subsets/*drug effects, Antibodies, Monoclonal, Humanized ; Epidermis/drug effects ; Etanercept ; Female ; Flow Cytometry ; Humans ; Male ; Middle Aged ; Psoriasis/immunology ; Severity of Illness Index ; T-Lymphocyte Subsets/immunology ; Treatment Outcome
-
8دورية أكاديمية
المؤلفون: Driessen RJ; Department of Dermatology, Radboud University Medical Centre, PO Box 9101, 6525 GL Nijmegen, The Netherlands. r.driessen@derma.umcn.nl, Berends MA, Boezeman JB, van de Kerkhof PC, de Jong EM
المصدر: The British journal of dermatology [Br J Dermatol] 2008 May; Vol. 158 (5), pp. 1098-106. Date of Electronic Publication: 2008 Mar 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0007-0963 (Print) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Immunoglobulin G/*therapeutic use , Immunosuppressive Agents/*therapeutic use , Psoriasis/*drug therapy , Receptors, Tumor Necrosis Factor/*therapeutic use, Adult ; Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Cohort Studies ; Etanercept ; Female ; Humans ; Immunoglobulin G/adverse effects ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Prospective Studies
-
9دورية أكاديمية
المؤلفون: van Lingen RG; Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. R.vanlingen@derma.umcn.nl, de Jong EM, Berends MA, Seyger MM, van Erp PE, van de Kerkhof PC
المصدر: The Journal of dermatological treatment [J Dermatolog Treat] 2008; Vol. 19 (5), pp. 284-7.
نوع المنشور: Clinical Trial, Phase III; Journal Article
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print Cited Medium: Print ISSN: 0954-6634 (Print) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE
مواضيع طبية MeSH: Anti-Inflammatory Agents/*pharmacology , Antibodies, Monoclonal/*pharmacology , Dermatologic Agents/*pharmacology , Methotrexate/*pharmacology , Psoriasis/*metabolism , T-Lymphocytes/*drug effects, Adalimumab ; Adult ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Cell Compartmentation/drug effects ; Dermatologic Agents/therapeutic use ; Female ; Humans ; Lymphocyte Count ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Pilot Projects ; Psoriasis/drug therapy ; T-Lymphocytes/physiology
-
10دورية أكاديمية
المؤلفون: Berends MA; Department of Dermatology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6525 GL Nijmegen, The Netherlands. m.berends@derma.umcn.nl., van Oijen MG, Snoek J, van de Kerkhof PC, Drenth JP, Han van Krieken J, de Jong EM
المصدر: Archives of dermatology [Arch Dermatol] 2007 Dec; Vol. 143 (12), pp. 1515-9.
نوع المنشور: Evaluation Study; Journal Article
بيانات الدورية: Publisher: American Medical Assn Country of Publication: United States NLM ID: 0372433 Publication Model: Print Cited Medium: Internet ISSN: 1538-3652 (Electronic) Linking ISSN: 0003987X NLM ISO Abbreviation: Arch Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Chemical and Drug Induced Liver Injury* , Severity of Illness Index*, Dermatologic Agents/*adverse effects , Liver Diseases/*pathology , Methotrexate/*adverse effects , Psoriasis/*drug therapy, Biopsy ; Dermatologic Agents/therapeutic use ; Female ; Humans ; Liver/pathology ; Liver Diseases/classification ; Male ; Methotrexate/therapeutic use ; Reproducibility of Results ; Retrospective Studies ; Single-Blind Method